Introduction to Stivarga (Regorafenib) 40mg
Renib (Regorafenib) 40mg is a targeted prescription medicine used in the treatment of certain advanced cancers, particularly colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer). This medicine belongs to a specialized class of oncology drugs known for blocking tumor growth and slowing disease progression.
Renib (Regorafenib) 40mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Oral Cancer Therapies. It contains Regorafenib, which works by inhibiting multiple protein kinases involved in tumor growth and blood vessel formation.
In some markets, Renib 40mg is available as a generic brand containing the same active ingredient Regorafenib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Stivarga (Regorafenib)?
Stivarga is the original brand name for Regorafenib, an oral medication widely used for treating various advanced-stage cancers.
Regorafenib belongs to a class of medicines known as multikinase inhibitors. These medicines target multiple pathways involved in cancer cell growth and tumor angiogenesis.
Generic versions such as Renib 40mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Regorafenib is classified as a multikinase inhibitor with anti-angiogenic and antineoplastic properties.
How Regorafenib Works
It works in several ways:
- Blocks enzymes (kinases) that promote cancer cell growth
- Inhibits formation of new blood vessels (anti-angiogenesis)
- Slows tumor progression and spread
- Targets multiple signaling pathways involved in cancer development
Through these actions, Regorafenib helps control the progression of certain cancers.
How Stivarga Works in the Body
Cancer cells rely on signaling pathways and blood supply for survival. Stivarga interferes with these processes, reducing tumor growth and spread.
Key Actions of Regorafenib
- Inhibiting tumor angiogenesis (blood vessel formation)
- Blocking oncogenic signaling pathways
- Reducing tumor cell proliferation
- Promoting cancer cell death
Generic versions such as Renib deliver the same active compound for targeted cancer therapy when prescribed appropriately.
Medical Uses of Stivarga (Regorafenib) 40mg
Renib 40mg is prescribed for several advanced cancers.
Regorafenib for Colorectal Cancer
Used in patients with metastatic colorectal cancer who have received prior treatments.
Potential Benefits
- Slows disease progression
- Improves overall survival in advanced cases
- Helps control tumor growth
Regorafenib for Gastrointestinal Stromal Tumors (GIST)
Used when other treatments are no longer effective.
Treatment Benefits
- Provides disease control in resistant cases
- Delays tumor progression
Regorafenib for Liver Cancer
Used in hepatocellular carcinoma after prior therapy.
Treatment Benefits
- Extends survival in certain patients
- Helps manage tumor progression
Who Can Take Renib 40mg?
Because Regorafenib is a potent medicine, treatment must be supervised by an experienced oncologist.
Eligibility Criteria
Patients may be prescribed this medicine if they:
- Have advanced colorectal cancer, GIST, or liver cancer
- Have received prior cancer treatments
- Are medically fit for targeted therapy
Who Should Avoid Stivarga (Regorafenib) 40mg
This medicine should NOT be used by:
- Pregnant women or those planning pregnancy
- Patients with severe liver impairment without monitoring
- Individuals allergic to Regorafenib
Stivarga (Regorafenib) 40mg Dosage and Administration
Standard Dosage Guidelines
- Typical dose: 160mg daily (4 tablets of 40mg)
- Taken for 21 days followed by 7 days off (28-day cycle)
- Taken with a low-fat meal
- Tablets should be swallowed whole
Dosage Adjustments
Doctors may adjust the dose depending on:
- Liver function
- Side effects such as hypertension or hand-foot syndrome
- Patient tolerance
Side Effects of Renib 40mg
Common Side Effects
- Fatigue and weakness
- Diarrhea
- Loss of appetite
- High blood pressure
- Hand-foot skin reaction
Serious Side Effects
- Liver toxicity
- Severe hypertension
- Bleeding complications
- Heart problems
Patients should seek immediate medical attention if severe symptoms occur.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and sunlight. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Regorafenib safe for long-term use?
It may be used long-term in some patients under strict medical supervision with regular monitoring.
2. Is Regorafenib chemotherapy?
No. It is a targeted therapy that works by blocking cancer growth pathways.
3. Can Renib 40mg cure cancer?
It does not cure cancer but helps control disease progression and improve survival.
4. Can patients take Renib with food?
Yes, it should be taken with a low-fat meal for better absorption.
5. Is Renib 40mg safe during pregnancy?
No. It may harm the unborn baby and must not be used during pregnancy.
6. Is Renib the same as Stivarga?
Renib contains Regorafenib, the same active ingredient found in Stivarga. Generic versions may vary by manufacturer.
7. Do I need a prescription to buy Renib 40mg?
Yes. It is a prescription-only medicine and must be used under medical supervision.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational purposes only and should not be considered medical advice. Regorafenib is a prescription-only medication and must be used under the supervision of a qualified healthcare professional. Always consult your doctor before starting or stopping any medication.
